You and me both mate. But if all goes to plan, there will come a...

You and me both mate. But if all goes to plan, there will come a time where the market does understand. Either an easy to interpret and incredible trial result, a licensing agreement, or a TO offer (hopefully not the last one given how undervalued we are).

But I stand by my response. Yuman Fong presenting at Bioshares is not surprising, don't read into it.

Put it this way, amazing data won't be embargoed for Bioshares. But it could be for one of the major international oncology conferences, depending on timing and whether the can keep the info under wraps.